FDA Warning Letter — Exxon

Case 519885 — FEI 3013342846

The FDA took a Warning Letter action against Exxon on Mar 16, 2017 (Washington, DC). The action was issued by CTP and concerns tobacco products.

Action details

Facility
Exxon
Date
Mar 16, 2017
Fiscal Year
2017
Product Type
Tobacco
Center
CTP
Location
Washington, DC (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.